Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing Safety and Efficacy of ASP4345 for schizophrenia.
Multiple locations, including CerritosThis study is completed in the United States. It is testing Safety and Efficacy of Oral LPCN 1154A for Depression.
Multiple locations, including AnahiemThis study is completed in the United States. It is testing safety, Efficacy, and Pharmacokinetics of Miricorilant for schizophrenia.
Multiple locations, including Bentonville
This study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 for schizophrenia.
Multiple locations, including GlendaleThis study is completed in Rwanda. It is testing treatment of Schizophrenia With Paliperidone Palmitate for schizophrenia.
Multiple locations, including ButareThis study is completed in the United States, in the United Kingdom, and in Ireland. It is testing use of Methylone for PTSD.
Multiple locations, including DenverThis study is completed in the United States, in Brazil, and in Mexico. It focuses on schizophrenia.
Multiple locations, including Little RockThis study is completed in the United States, in Bulgaria, in Czechia, .... It focuses on schizophrenia.
Multiple locations, including Garden GroveThis study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Effectiveness and Safety of Prolonged Release OROS Methylphenidate for ADHD.
Multiple locations, including AntwerpThis study was terminated in the United States. It is testing efficacy, Safety, and Tolerability of Darigabat for Anxiety.
Multiple locations, including PhoenixThis study was withdrawn in the United States. It is testing iloperidone for Schizophrenia.
In St. PetersburgThis study is completed in the United States. It is testing Iloperidone Long-acting Injection (LAI) for schizophrenia.
Multiple locations, including Garden GroveHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.